| |
All patients
|
NACG
|
ACG
|
p
|
|---|
|
N = 60
|
N = 28 (%)
|
N = 32 (%)
|
|---|
|
Age (median)
|
41.0
|
41.5
|
40.5
|
0.410
|
|
Tumor size (cm)
|
8
|
7
|
8.4
|
0.523
|
|
Serum Ca125(U / ml)
|
15.5
|
14.4
|
16.4
|
0.751
|
|
Menopause
| | | |
0.744
|
|
Yes
|
14 (23.3)
|
6 (21.4)
|
8 (25.0)
| |
|
No
|
46 (76.7)
|
22 (78.6)
|
24 (75.0)
| |
|
FIGO stage (%)
| | | |
0.944
|
|
IC1
|
34 (56.7)
|
16 (57.1)
|
18 (56.2)
| |
|
IC2-IC3
|
26 (43.3)
|
12 (42.9)
|
14 (43.8)
| |
|
Surgical procedure
| | | |
0.605
|
|
Fertility surgery
|
30 (50.0)
|
15 (53.6)
|
15 (46.9)
| |
|
Radical surgery
|
30 (50.0)
|
13 (46.4)
|
17 (53.1)
| |
|
Staging operation
| | | |
0.102
|
|
Yes
|
26 (43.3)
|
9 (32.1)
|
17 (53.1)
| |
|
No
|
34 (56.7)
|
19 (67.9)
|
15 (46.9)
| |
|
Lymphadenectomy
| | | |
0.245
|
|
Yes
|
24 (40.0)
|
9 (32.1)
|
15 (46.9)
| |
|
No
|
36 (60.0)
|
19 (67.9)
|
17 (53.1)
| |
|
First operation at clinical
| | | |
0.696
|
|
Our clinical
|
37 (61.7)
|
18 (64.3)
|
19 (59.4)
| |
|
Outer
|
23 (38.3)
|
10 (35.7)
|
13 (40.6)
| |
- AGCT: adult granulosa cell tumor; ACG: adjuvant chemotherapy group; NACG: no adjuvant chemotherapy group
